Fundraising Fox
Oxford Performance Materials
South Windsor, US · Founded 2011 · Delaware corporation · 40 employees on LinkedIn · 1 known investors
Find your way into Oxford Performance Materials
Sign up to see every warm intro you have to Oxford Performance Materials
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oxford Performance Materials team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oxford Performance Materials develops additive manufacturing (3D printing) technology and high-performance PEKK thermoplastics and coatings. Its products serve medical device applications, such as surgical implants via its OsteoFab platform, and industrial hardware markets through its OXFAB platform.
Founders & leadership
Oxford Performance Materials was founded in 2011 by Scott DeFelice.
JD
Jordan DeFeliceChief Operating OfficerJordan DeFelice is COO of Oxford Performance Materials, where he oversees operational strategy and scaling of the company's 3D-printed medical implant platform. He holds a bachelor's degree in biology from Union College.
PM
Paul MartinPrincipal, Board Member, President Aerospace & Industrial Division2013–2016Paul Martin is an aerospace engineer with over 40 years of industry experience across flight systems, avionics, and advanced aircraft programs at organizations including Lockheed Martin Skunk Works, Sikorsky Aircraft, and the U.S. Air Force. He has led additive manufacturing and advanced materials development at Oxford Engineered Solutions and currently serves as an executive officer and director at Oxford Performance Materials.
SZ
Severine ZygmontExecutive
AD
Anthony DeCarmineExecutive
JS
Jacqueline SymingtonCorporate Controller2007–2017Jacqueline Symington is Executive Officer at Oxford Performance Materials, which develops additive manufacturing technology and high-performance thermoplastics for medical device and industrial applications. She brings extensive operations, finance, and accounting expertise including FP&A, budgeting, procurement, and ERP implementation across multiple industries.
Board
MF
Marc FasteauBoard director
RF
Robert FiondellaBoard director
AE
Amy EvansBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$37.9M disclosed across 5 rounds · 2014–2025
▶$355KraisedJul 2025 · 7 investors · OtherRule 506(b)
▶$355KraisedJul 2025 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jordan DeFeliceExecutive Officer, Director
- Marc FasteauDirector
- Robert FiondellaDirector
- Scott DeFeliceExecutive Officer, Director
- Amy EvansDirector
- Offering amount
- $5M
- Amount sold
- $355K
- Minimum investment
- $25K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.8MraisedFeb 2017 · 22 investors · OtherRule 506(b)
▶$10.8MraisedFeb 2017 · 22 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Marc FasteauDirector
- Lawrence VarholakExecutive Officer
- Christopher CodeanneExecutive Officer, Director
- Scott F DeFeliceExecutive Officer, Director
- Robert FiondellaDirector
- Severine ZygmontExecutive Officer, Director
- Brett SchneiderDirector
- Offering amount
- $10.8M
- Amount sold
- $10.8M
- Minimum investment
- $1
- Sales commissions
- $350K
- Placement agents
- Barclays Capital Inc., NewCap Partners Inc.
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.8MraisedJun 2016 · 6 investors · OtherRule 506(b)
▶$15.8MraisedJun 2016 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence VarholakExecutive Officer
- Scott F DeFeliceExecutive Officer, Director
- Severine ZygmontExecutive Officer, Director
- Christopher CodeanneExecutive Officer, Director
- Brett SchneiderDirector
- Offering amount
- $15.8M
- Amount sold
- $15.8M
- Minimum investment
- $1
- Sales commissions
- $255K
- Proceeds to insiders
- $800K
- Placement agents
- NewCap Partners Inc.
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedOct 2015 · 23 investors · OtherRule 506(b)
▶$5.4MraisedOct 2015 · 23 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Paul MartinExecutive Officer, Director
- Severine ZygmontExecutive Officer, Director
- Anthony DeCarmineExecutive Officer
- Christopher CodeanneExecutive Officer
- Jacqueline SymingtonExecutive Officer
- Scott F DeFeliceExecutive Officer, Director
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- Minimum investment
- $10K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$5.5MraisedDec 2014 · 37 investors · OtherRule 506(b)
▶$5.5MraisedDec 2014 · 37 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Severine ZygmontExecutive Officer, Director
- Paul W MartinExecutive Officer, Director
- Scott F DeFeliceExecutive Officer, Director
- Anthony DeCarmineExecutive Officer
- Jacqueline SymingtonExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- Minimum investment
- $25K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Sparta BiomedicalSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.
Companies working in the same space as Oxford Performance Materials.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $202.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Oxford Performance Materials do?
- Oxford Performance Materials develops additive manufacturing (3D printing) technology and high-performance PEKK thermoplastics and coatings. Its products serve medical device applications, such as surgical implants via its OsteoFab platform, and industrial hardware markets through its OXFAB platform.
- Who founded Oxford Performance Materials?
- Oxford Performance Materials was founded by Scott DeFelice in 2011.
- Who are Oxford Performance Materials's investors?
- Oxford Performance Materials's investors include Brightlands Venture Partners.
- How much funding has Oxford Performance Materials raised?
- Oxford Performance Materials has disclosed $37.9M raised across 5 rounds.
- Where is Oxford Performance Materials headquartered?
- Oxford Performance Materials is headquartered in South Windsor, US.